Quanterix Corp (OQ:QTRX)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for QTRX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 21/20 Feb 21/20 Madaus Martin D Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -1,600  
Feb 21/20 Feb 21/20 Madaus Martin D Indirect Ownership Common Stock S - Open market or private sale -2,300 $27.98
Feb 21/20 Feb 21/20 Madaus Martin D Direct Ownership Common Stock S - Open market or private sale -1,600 $28.26
Feb 21/20 Feb 21/20 Madaus Martin D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,600 $1.93
Feb 21/20 Feb 20/20 Madaus Martin D Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -1,600  
Feb 21/20 Feb 20/20 Madaus Martin D Indirect Ownership Common Stock S - Open market or private sale -100 $28.58
Feb 21/20 Feb 20/20 Madaus Martin D Indirect Ownership Common Stock S - Open market or private sale -2,200 $28.11
Feb 21/20 Feb 20/20 Madaus Martin D Direct Ownership Common Stock S - Open market or private sale -1,600 $28.29
Feb 21/20 Feb 20/20 Madaus Martin D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,600 $1.93
Feb 20/20 Feb 18/20 Fry John J Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 26,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for QTRX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 21/20 Feb 21/20 Madaus Martin D Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -1,600  
Feb 21/20 Feb 20/20 Madaus Martin D Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -1,600  
Feb 21/20 Feb 21/20 Madaus Martin D Indirect Ownership Common Stock S - Open market or private sale -2,300 $27.98
Feb 21/20 Feb 21/20 Madaus Martin D Direct Ownership Common Stock S - Open market or private sale -1,600 $28.26
Feb 21/20 Feb 21/20 Madaus Martin D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,600 $1.93
Feb 21/20 Feb 20/20 Madaus Martin D Indirect Ownership Common Stock S - Open market or private sale -100 $28.58
Feb 21/20 Feb 20/20 Madaus Martin D Indirect Ownership Common Stock S - Open market or private sale -2,200 $28.11
Feb 21/20 Feb 20/20 Madaus Martin D Direct Ownership Common Stock S - Open market or private sale -1,600 $28.29
Feb 21/20 Feb 20/20 Madaus Martin D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,600 $1.93
Feb 20/20 Feb 18/20 Fry John J Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 26,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $QTRX

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Alnylam Pharmaceuticals (OQ:ALNY)
Vir Biotechnology (OQ:VIR)